Insulet (PODD) Shares Outstanding (2010 - 2026)
Insulet's (PODD) quarterly Shares Outstanding (Entity) came in at $70.7 million in Q1 2026, little changed YoY from $70.4 million in Q1 2025, and little changed on a QoQ basis from $70.6 million in Q4 2025.
Insulet (PODD) Shares Outstanding (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Shares Outstanding (Entity) data on file, last reported at $70.7 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) changed 0.5% year-over-year to $70.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.7 million (changed 0.5% YoY) and the FY2025 annual result came in at $70.6 million, up 0.56% from the prior year.
- Shares Outstanding (Entity) was little changed at $70.7 million in Q1 2026, from $70.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $70.7 million in Q1 2026 to a low of $69.3 million in Q1 2022.
- A 5-year average of $70.0 million and a median of $70.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) climbed 4.69% — and 2024, when it advanced 0.41%.
- Tracing PODD's Shares Outstanding (Entity) over 5 years: stood at $69.5 million in 2022, then grew by 0.57% to $69.9 million in 2023, then grew by 0.41% to $70.2 million in 2024, then rose by 0.56% to $70.6 million in 2025, then climbed by 0.17% to $70.7 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $70.7 million (Q1 2026), $70.6 million (Q4 2025), and $70.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Insulet | 10.37 Bn | 9.84 Bn | 562.60 Mn | 69.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.30 Mn |
| Mar 31, 2026 | 69.99 Mn |
| Dec 31, 2025 | 70.35 Mn |
| Sep 30, 2025 | 70.37 Mn |
| Jun 30, 2025 | 70.39 Mn |
| Mar 31, 2025 | 70.27 Mn |
| Dec 31, 2024 | 70.08 Mn |
| Sep 30, 2024 | 70.12 Mn |
| Jun 30, 2024 | 70.06 Mn |
| Mar 31, 2024 | 69.96 Mn |
| Dec 31, 2023 | 69.75 Mn |
| Sep 30, 2023 | 69.82 Mn |
| Jun 30, 2023 | 69.74 Mn |
| Mar 31, 2023 | 69.58 Mn |
| Dec 31, 2022 | 69.38 Mn |
| Sep 30, 2022 | 69.42 Mn |
| Jun 30, 2022 | 69.36 Mn |
| Mar 31, 2022 | 69.25 Mn |
| Dec 31, 2021 | 67.70 Mn |
| Sep 30, 2021 | 68.87 Mn |